Key result
Left bundle branch area pacing for cardiac resynchronization was associated with similar clinical outcomes to biventricular pacing, but fewer device-related complications (1% vs 11%; HR 0.10).
Why the study?
LBBAP has emerged as an alternative to conventional BIVP for CRT, but existing evidence suggesting it may provide superior outcomes requires more data.
Does left bundle branch area pacing improve procedural and clinical outcomes compared to biventricular pacing in patients undergoing de-novo cardiac resynchronization therapy?
Cohort (n=314)
Yes
Does left bundle branch area pacing improve procedural and clinical outcomes compared to biventricular pacing in patients undergoing de-novo cardiac resynchronization therapy?
Effect estimate: HR 0.10 (95% CI 0.01-0.84)
Absolute Event Rate: 1% vs 11%
p-value: p=0.033
In patients requiring de-novo cardiac resynchronization therapy, left bundle branch area pacing offers similar clinical and echocardiographic outcomes to biventricular pacing, but with shorter procedure times, narrower paced QRS, and fewer late device-related complications.
Background Left bundle branch area pacing (LBBAP) has emerged as a promising alternative to conventional biventricular pacing (BIVP) for cardiac resynchronization therapy (CRT). While previous data suggest LBBAP may provide superior outcomes, existing evidence needs more data. Methods This retrospective study included all patients who underwent de‐novo CRT at two centers in France (2022–2024). Procedural and clinical outcomes were compared between LBBAP and BIVP groups for de‐novo CRT indications, using inverse probability weighting propensity score. Results A total of 314 patients were included (75 LBBAP, 239 BIVP). Patients receiving LBBAP were older and more likely to have atrial fibrillation. Compared to BIVP, LBBAP was associated with shorter procedure time (96 vs. 128 min; p < 0.001), narrower paced QRS (128 vs. 139 ms; p < 0.001), and lower post‐discharge device‐related complications (1% vs. 11%; HR 0.10, 95% CI 0.01–0.84; p = 0.033). At 1‐year, improvement in left ventricular ejection fraction (LVEF) was similar between groups (median ΔLVEF +15%; p = 0.438), as were hyper‐response rates (52% vs. 60%; p = 0.231). After IPW‐PS, no significant differences were observed in heart failure hospitalization (HR 0.99, 95% CI 0.40–2.64; p = 0.999), new‐onset atrial fibrillation (HR 1.69, 95% CI 0.41–6.94; p = 0.492), sustained ventricular arrhythmias (HR 1.23, 95% CI 0.15–6.49; p = 0.828), overall (HR 1.10, 95% CI 0.44–2.62; p = 0.801), and cardiovascular deaths (HR 0.92, 95% CI 0.27–2.79; p = 0.927). Conclusion LBBAP is associated with comparable resynchronization and clinical outcomes to BIVP, with fewer late complications.
No takes yet. Share an insight, caveat, or question.
Kerkouri et al. (2026) conducted a cohort in cardiac resynchronization therapy indications (n=314). Left bundle branch area pacing vs. Biventricular pacing was evaluated on post-discharge device-related complications (HR 0.10, 95% CI 0.01-0.84, p=0.033). Left bundle branch area pacing for cardiac resynchronization was associated with similar clinical outcomes to biventricular pacing, but fewer device-related complications (1% vs 11%; HR 0.10).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: